POINT-OF-CARE TESTING MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST

  2024-11-27 |   Pages: 200+ |   Report ID: BYR-88594 |   Pharmaceuticals And Medical

Historical data: 2017 - 2023

Forecast period: 2025 - 2031

Quantitative units: Revenue in USD million and CAGR from 2025 to 2031

Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Point-of-Care Testing Market

Image

1.1 SCOPE OF THE REPORT

1.2 MARKET SEGMENT ANALYSIS

1.3 REGULATORY SCENARIO BY REGION/COUNTRY

1.4 MARKET INVESTMENT SCENARIO STRATEGIC

1.5 MARKET ANALYSIS BY TYPE (USD MILLION)

1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)

2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS

  2.1.1 MARKET DRIVER ANALYSIS

  2.1.2 MARKET RESTRAINT ANALYSIS

  2.1.3 MARKET OPPORTUNITY

  2.1.4 MARKET CHALLENGES

3.1 INDUSTRY TRENDS

  3.1.1 SWOT ANALYSIS

  3.1.2 PESTEL ANALYSIS

  3.1.3 PORTER’S FIVE FORCES ANALYSIS

3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS

4.1 COVID-19 ANALYSIS

5.1 GLOBAL POINT-OF-CARE TESTING MARKET, SALES AREA, TYPE

5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL POINT-OF-CARE TESTING MARKET

7.1 GLOBAL POINT-OF-CARE TESTING MARKET SIZE AND SHARE (2017 - 2031) (USD MILLION)

8.1 GLOBAL POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)

8.2 GLOBAL POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)

9.1 GLOBAL POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)

9.2 GLOBAL POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)

10.1 GLOBAL POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY REGION (2017 - 2023) (USD MILLION)

10.2 GLOBAL POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY REGION (2025 - 2031) (USD MILLION)

11.1 NORTH AMERICA POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)

11.2 NORTH AMERICA POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)

11.3 NORTH AMERICA POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)

11.4 NORTH AMERICA POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)

11.5 NORTH AMERICA POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)

11.6 NORTH AMERICA POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)

12.1 EUROPE POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)

12.2 EUROPE POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)

12.3 EUROPE POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)

12.4 EUROPE POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)

12.5 EUROPE POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)

12.6 EUROPE POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)

13.1 ASIA PACIFIC POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)

13.2 ASIA PACIFIC POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)

13.3 ASIA PACIFIC POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)

13.4 ASIA PACIFIC POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)

13.5 ASIA PACIFIC POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)

13.6 ASIA PACIFIC POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)

14.1 LATIN AMERICA POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)/p>

14.2 LATIN AMERICA POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)

14.3 LATIN AMERICA POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)

14.4 LATIN AMERICA POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)

14.5 LATIN AMERICA POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)

14.6 LATIN AMERICA POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)

15.1 MIDDLE EAST & AFRICA POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)

15.2 MIDDLE EAST & AFRICA POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)

15.3 MIDDLE EAST & AFRICA POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)

15.4 MIDDLE EAST & AFRICA POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)

15.5 MIDDLE EAST & AFRICA POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)

15.6 MIDDLE EAST & AFRICA POINT-OF-CARE TESTING MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031)< (USD MILLION)/p>

16.1 BioSpectrum Asia

  16.1.1 COMPANY DETAILS

  16.1.2 FINANCIALS (USD MILLION)

  16.1.3 PRODUCT SUMMARY

  16.1.4 RECENT DEVELOPMENTS

16.2 Fosun Pharma

16.3 Johnson & Johnson

16.4 Sysmex Corporation

16.5 HemoCue India

16.6 DiaSys India

16.7 Siemens Healthineers India

16.8 Operon Biotech

16.9 Roche Diagnostics India

16.10 Abbott Laboratories Inc

16.11 Beckman Coulter Inc

16.12 Becton

16.13 Acrongenomics Inc

16.14 Dickinson and Company

16.15 Alere Inc

16.16 Instrumentation Laboratory

16.17 PTS Diagnostics

16.18 Abaxis Inc

16.19 Medtronic

16.20 Accriva Diagnostics

16.21 OPTI Medical

16.22 Sienco Inc

16.23 AccuBioTech Co Ltd

16.24 ACON Laboratories Inc

16.25 bioMerieux SA

16.26 Biomerica Inc

16.27 Atlas Genetics Ltd

16.28 Alfa Scientific Designs Inc

16.29 Alpha Scientific

16.30 Bio-Rad Laboratories Inc

16.31 Medica Corporation

16.32 Nova Biomedical

18.1 METHODOLOGY

18.2 RESEARCH DATA SOURCE

  18.2.1 SECONDARY DATA

  18.2.2 KEY DATA FROM SECONDARY

  18.2.3 PRIMARY DATA

  18.2.4 KEY DATA FROM PRIMARY

  18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS

  18.2.6 MARKET ESTIMATION

  18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH

  18.2.8 LEGAL DISCLAIMER

Market Segments

By Type
Blood Glucose Testing Kits
Cardiometabolic Monitoring Kits
Infectious Disease Testing Kits
Cholesterol Testing Kits
Pregnancy and Fertility Tests Kits
Tumor/Cancer Markers
Urinalysis Testing Kits
Cholesterol Test Strips
Hematology Testing Kits
Drugs of Abuse Testing Kits
Fecal Occult Testing Kits
Rapid Coagulation Testing Kits
Others

By Application
Cardiology
Critical Care
Diabetes
Endocrinology
Liver Diseases
Maternal Fetal
Neonatology

Companies

BioSpectrum Asia
Fosun Pharma
Johnson & Johnson
Sysmex Corporation
HemoCue India
DiaSys India
Siemens Healthineers India
Operon Biotech
Roche Diagnostics India
Abbott Laboratories Inc
Beckman Coulter Inc
Becton
Acrongenomics Inc
Dickinson and Company
Alere Inc
Instrumentation Laboratory
PTS Diagnostics
Abaxis Inc
Medtronic
Accriva Diagnostics
OPTI Medical
Sienco Inc
AccuBioTech Co Ltd
ACON Laboratories Inc
bioMerieux SA
Biomerica Inc
Atlas Genetics Ltd
Alfa Scientific Designs Inc
Alpha Scientific
Bio-Rad Laboratories Inc
Medica Corporation
Nova Biomedical

BROWSE INDUSTRY

  1. Consumer Goods
  2. Healthcare
  3. Food & Beverage
  4. Heavy Industry
  5. Service Industries
  6. FMCG
  7. Life Sciences
  8. Technology & Media
  9. Machinery & Equipment

    WHY CHOOSE US

  •   PROACTIVE
  • We manage our resources 24/7 to identify issues and address them before they become problems.

  •   QUALITY & RELIABILITY
  • We are committed to providing reliable and highly accurate data with an excellent quality control system.

  •   GLOBAL OUTREACH
  • 6 Major regions and 40+ countries level analysis accomplished.

  •   COMPETITIVE PRICING
  • Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.